Associated Papers
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
Zhang C et al.
Cell Reports. Medicine, 2024
38897205 (PubMed )
Supplement: mmc10.xlsx › Sheet1
Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma.
Thibodeau ML et al.
Cold Spring Harbor Molecular Case Studies, 2017
28514723 (PubMed )
Supplement: supp_mcs.a001628_Supplemental_Table_S1.xlsx › small_mutations
Select a paper to view details